Improved memory with AL 108 in mild cognitive impairment

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1651, 2008-01, pp. : 1-1

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The status of ongoing trials for mild cognitive impairment

By Sramek J.J. Veroff A.E. Cutler N.R.

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 4, 2001-04 ,pp. : 741-752

Informa Healthcare

Access to resources Recommend Favorite

Identifying Amnestic Mild Cognitive Impairment in Primary Care: A Feasibility Study

By Doody Rachelle S.

Clinical Drug Investigation, Vol. 31, Iss. 7, 2011-07 ,pp. : 483-491

Adis International

Access to resources Recommend Favorite

NMDA Neurotransmission Dysfunction in Mild Cognitive Impairment and Alzheimer’s Disease

Current Pharmaceutical Design, Vol. 20, Iss. 32, 2014-10 ,pp. : 5169-5179

Bentham Science Publishers

Access to resources Recommend Favorite

Cognitive impairment associated with HIV-1 infection seems to be improved by HAART

Inpharma, Vol. 1, Iss. 1277, 2001-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

A Systematic Review of Amnestic and Non-Amnestic Mild Cognitive Impairment Induced by Anticholinergic, Antihistamine, GABAergic and Opioid Drugs

By Tannenbaum Cara Paquette Amélie

Drugs & Aging, Vol. 29, Iss. 8, 2012-08 ,pp. : 639-658

Adis International

Access to resources Recommend Favorite